On April 10, 2018, Partner Stephen Goodman, Co-Chair of Pryor Cashman's Life Sciences Group, will moderate a panel at the Redefining Early Stage Investments (RESI) on MaRS Conference in Toronto, Canada. Goodman, who is also co-founder of Mid Atlantic Bio Angels - a life science angel investor group - and his fellow panelists will explore how angel groups approach an investment opportunity and how best to pitch / work with an angel investor, as well as how to work with other angel groups and VCs, what to expect in the diligence process, cap table issues and more.
To learn more about this event, or to register, please visit here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.